GlobeNewswire Inc.··DelveinsightHemophilia Treatment Revolution: 50+ Companies Race to Transform Patient Care
Over 50 drugmakers advance 55+ hemophilia treatments as Novo Nordisk and competitors pursue gene therapies and next-gen factors.
NVORHHBYREGNBAYRYMGXclinical trialsgene therapy